Figure 1From: The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea Treatment modality (A) and treatment response (B) of 26 esophageal neuroendocrine tumors (NETs). Because of most esophageal NETs were already showing metastasis at the time of diagnosis, prognosis of them did not show benign course. On the other hand, 26.9% of patients showed complete response and all of them were completely removable via endoscopic or surgical methods.Back to article page